HRTX

Heron Therapeutics, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$0.33

Price (1 Year)

$1.49 $0.28

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %48.3 / %30
Non-compliant assets / Total market cap %4.5 / %30
Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.

Website

Analysis (Turkish): HRTX Hissesi Caiz mi, Helal mi? Heron Therapeutics, Inc. Katılım Analizi